BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 17, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 16, 1998

View Archived Issues

British Biotech: Q1 1998/99 highlights and shareholder update at AGM

Read More

New treatment option now available for type II diabetics in the U.K.

Read More

Creative BioMolecules modifies Biogen partnership

Read More

Aquila reports preliminary results of phase II trial of pneumococcal vaccine

Read More

Faulding Canada to promote ImmunoCyt in Canada

Read More

Taxol combination therapy approved in France for NSCLC indication

Read More

Endorex adds second site to phase II ImmTher trial

Read More

Novel anticancer agent from ProScript moves into clinical testing

Read More

Hemosol successfully completes U.K. Hemolink trial

Read More

Data safety monitoring board deems Nabi S. aureus vaccine safe in hemodialysis patients

Read More

New animal model of bone metastasis developed at AntiCancer

Read More

Vanguard Medica: six-month highlights

Read More

Scientists at Cell Therapeutics disclose new signal transduction inhibitors

Read More

Alcon licenses ciprofloxacin otic products from Bayer

Read More

Janssen product pipeline updated

Read More

Discovery of MRI contrast agents focus of Epix and NeoGenesis collaboration

Read More

E.U. approval granted for rabeprazole; product launched in U.K.

Read More

Patent protection for method of treating neurodegenerative disorders pioneered by NeoTherapeutics

Read More

Scripps uses DGT's gene expression technology to discover new treatments for HBV

Read More

Boston Scientific to copromote Targis System for BPH

Read More

Gene for Rx, Dx of liver cancer available for licensing from RCT

Read More

Alza now marketing MacroBID and Macrodantin in Canada

Read More

Orphan drug designation granted to MEDI-507 for use in AlloMune system

Read More

Vitrase to be fast-tracked by FDA

Read More

First FDA approval for once-daily use of an inhaled corticosteroid for asthma

Read More

Wayne Hughes Institute develops potent new agent for breast cancer

Read More

U.S. availability of new broad-spectrum cephalosporin antibiotic announced

Read More

Certiva vaccine launched in the U.S.

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 17, 2026.
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 14, 2026
  • Cancer cell in the cross-hairs

    Selective CBL-B inhibitor with improved safety profile disclosed

    BioWorld Science
    CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
  • MSD discloses new HCN1/2 blockers

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing